Impact of molecular biology studies on the understanding of brain tumors in childhood (Q48716816)

14 February 2018

title

Impact of molecular biology studies on the understanding of brain tumors in childhood (English)

1 reference

14 February 2018

0 references

1 reference

Amulya A Nageswara Rao

series ordinal

1

1 reference

14 February 2018

Roger J Packer

series ordinal

2

1 reference

14 February 2018

publication date

1 April 2012

1 reference

14 February 2018

published in

Current Oncology Reports

1 reference

14 February 2018

volume

14

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

206-212

1 reference

14 February 2018

Long-Term Effects of Radiation Exposure among Adult Survivors of Childhood Cancer: Results from the Childhood Cancer Survivor Study

cites work

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Late effects of therapy for pediatric brain tumor survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Medulloblastoma in childhood: new biological advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Medulloblastoma: present concepts of stratification into risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Stratification of medulloblastoma on the basis of histopathological grading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

c-myc overexpression causes anaplasia in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Medulloblastoma associated with novel PTCH mutation as primary manifestation of Gorlin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Medulloblastoma and glioblastoma multiforme in a patient with Turcot syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Novel roles for APC family members and Wingless/Wnt signaling during Drosophila brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Subtypes of medulloblastoma have distinct developmental origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Role of Wnt pathway in medulloblastoma oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Notch signaling, gamma-secretase inhibitors, and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

PDGFRB is overexpressed in metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Molecular genetics of atypical teratoid/rhabdoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Analysis of pilocytic astrocytoma by comparative genomic hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Tyrosine kinase expression in pediatric high grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Molecular pathogenesis of pediatric astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Clinical and molecular characteristics of malignant transformation of low-grade glioma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

MGMT promoter methylation in pediatric high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Comparative genomic hybridization detects an increased number of chromosomal alterations in large cell/anaplastic medulloblastomas.

21 January 2018

2 references

https://api.crossref.org/works/10.1007/S11912-012-0214-3

21 January 2018

12 December 2020

Nonsense Mutation and Inactivation of SMARCA4 (BRG1) in an Atypical Teratoid/Rhabdoid Tumor Showing Retained SMARCB1 (INI1) Expression

1 reference

https://api.crossref.org/works/10.1007/S11912-012-0214-3

Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort

21 January 2018

1 reference

12 December 2020

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

1 reference

12 December 2020

[Differential expression of Notch1 and Notch2 in astrocytoma and medulloblastoma].

1 reference

12 December 2020

Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with a focal amplification at chromosome 19q13.42 locus: Further evidence of two new instances in China

1 reference

12 December 2020

Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas

1 reference

12 December 2020

Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors

1 reference

12 December 2020

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

1 reference

12 December 2020

MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA

1 reference

12 December 2020

Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics

1 reference

12 December 2020

The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors

1 reference

12 December 2020

Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid

1 reference

12 December 2020

Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas

1 reference

12 December 2020

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma

1 reference

12 December 2020

INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma

1 reference

12 December 2020

10.1007/S11912-012-0214-3

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018